Mora S - Search Results

1

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ. Boekholdt SM, et al. Among authors: mora s. JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366. JAMA. 2012. PMID: 22453571

2

Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study.

Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS. Mora S, et al. JAMA. 2003 Sep 24;290(12):1600-7. doi: 10.1001/jama.290.12.1600. JAMA. 2003. PMID: 14506119

3

Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

Mora S, Ridker PM. Mora S, et al. Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1. Am J Cardiol. 2006. PMID: 16442935 Review.

4

Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.

Mora S, Lee IM, Buring JE, Ridker PM. Mora S, et al. JAMA. 2006 Mar 22;295(12):1412-9. doi: 10.1001/jama.295.12.1412. JAMA. 2006. PMID: 16551713

5

Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.

Mora S, Rifai N, Buring JE, Ridker PM. Mora S, et al. Circulation. 2006 Aug 1;114(5):381-7. doi: 10.1161/CIRCULATIONAHA.106.634089. Epub 2006 Jul 24. Circulation. 2006. PMID: 16864722

6

Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.

Zee RY, Mora S, Cheng S, Erlich HA, Lindpaintner K, Rifai N, Buring JE, Ridker PM. Zee RY, et al. Among authors: mora s. Clin Chem. 2007 May;53(5):845-51. doi: 10.1373/clinchem.2006.083881. Epub 2007 Mar 1. Clin Chem. 2007. PMID: 17332146

7

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Bansal S, et al. Among authors: mora s. JAMA. 2007 Jul 18;298(3):309-16. doi: 10.1001/jama.298.3.309. JAMA. 2007. PMID: 17635891

8

Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study.

Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Conen D, et al. Among authors: mora s. Eur Heart J. 2007 Dec;28(23):2937-43. doi: 10.1093/eurheartj/ehm400. Epub 2007 Oct 9. Eur Heart J. 2007. PMID: 17925342

9

Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms.

Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Mora S, et al. Circulation. 2007 Nov 6;116(19):2110-8. doi: 10.1161/CIRCULATIONAHA.107.729939. Epub 2007 Oct 22. Circulation. 2007. PMID: 17967770 Free PMC article.

10

Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Mora S, Rifai N, Buring JE, Ridker PM. Mora S, et al. Circulation. 2008 Sep 2;118(10):993-1001. doi: 10.1161/CIRCULATIONAHA.108.777334. Epub 2008 Aug 18. Circulation. 2008. PMID: 18711012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

700 results

Search Page